GAMMA Investing »

Crinetics Pharmaceuticals In shares owned by GAMMA Investing

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.7k 58 46.81
2023-12-31 $1.5k 42 36.48

More positions owned by GAMMA Investing

Microsoft Corp Common Stock (MSFT)
Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Jpmorgan Chase Common Stock (JPM)
Meta Platforms Inc Cl A Common Stock (META)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Ishares Tr National Mun Etf Etf (MUB)
Visa Inc Com Cl A Common Stock (V)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Ishares Inc Core Msci Emkt Etf (IEMG)
Eli Lilly Common Stock (LLY)
Home Depot Common Stock (HD)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)

View all positions for GAMMA Investing

Top funds holding Crinetics Pharmaceuticals In

Vanguard Group
Point72 Asset Management
Wellington Management Company
T. Rowe Price Associates
Jennison Associates
Paradigm Biocapital Advisors
EcoR1 Capital
First Light Asset Management
OrbiMed Advisors
Perceptive Advisors
Cormorant Asset Management
Eventide Asset Management
Ikarian Capital
Lord, Abbett & Co
Dimensional Fund Advisors

View all funds holding Crinetics Pharmaceuticals In